Clinical radiopharmacy: Principles and practices

Seminars in Nuclear Medicine

Volumn 26, Issue 2, 1996, Pages 77-84

  Rhodes, Buck A ^a,b   Hladik III, William B ^a   Norenberg, Jeffrey P ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b RhoMed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

ARTICLE; EDUCATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; NUCLEAR MEDICINE; ORGANIZATION AND MANAGEMENT; PHARMACY; QUESTIONNAIRE; STANDARD; UNITED STATES;

EDUCATION, PHARMACY; HEALTH CARE REFORM; HEALTH PERSONNEL; HUMANS; NUCLEAR MEDICINE; PHARMACEUTICAL SERVICES; QUESTIONNAIRES; RADIOISOTOPES; UNITED STATES;

EID: 70449853216     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-2998(96)80028-6     Document Type: Article

References (23)

1. Kepler CD, Strand LM: Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533-543,1990
2. Helper CD: The future of pharmacy: Pharmaceutical care. Am Pharm NS30(10):23-29,1990
3. Strand LM, Cipolle RJ, Morley PC: Pharmaceutical care: An introduction. Kalamazoo, MI, The Upjohn Co, 1992
4. Kawada T, Tubis M, Ebenkamp T, et al: Review of nuclear pharmacy practice in hospitals. Am J Hosp Pharm 39:266-274,1982
5. Constantine LM, Scott S: Winning payment for cognitive services: What works. Am Pharm 35(9):14-16,1995
6. Perri HI M: Eight steps toward payment for cognitive services. Am Pharm NS35(9):20-25,1995
7. Rupp MT: Standardizing documentation for filing pharmaceutical care claims. Am Pharm NS35(9):26-30, 1995
8. Graubart JI: The toll we've been waiting for. Am Pharm NS35(9):64,1995
9. Hladik WB, Norenberg JP: Drug-radiopharmaceutical interactions that impact patient care. Appl Therap Inc 14:785-789,1994
10. Laven DL, Shaw SM: Detection of drug interactions involving radiopharmaceuticals: A professional responsibility of the clinical pharmacist. J Pharm Pract 2:287-298,1989
11. Ginsberg M, Roberte R, Trujillo E, et al: Patient exposures to HIV during nuclear medicine procedures. MMWR 41:575-578,1992
12. Centers for Disease Control: Three nuclear medicine injection errors transmit HIV. Radiol Today October, 1992, p 8
13. Loudin A: Routine exam leads to death. RT Image 4 23-25,1991
14. Norenberg JP, Hladik WB: Therapeutic drug monitoring using nuclear medicine techniques. Correspondence Continuing Education for Nuclear Pharmacists (vol 14, no 5). Albuquerque, NM: The University of New Mexico College of Pharmacy, 1996
15. Laven DL, Hladik III WB: Pharmaceutical care and diagnostic pharmaceuticals: Patient care avenues not to be overlooked. J Pharm Pract 7:79-83,1994
16. American Pharmaceutical Association: Policy on the pharmacists role with diagnostic drugs in therapeutic outcomes. Am Pharm NS33(7):56,1993
17. Hatoum HT, Hutchinson RA, Lambert BL: OBRA 90: Patient counseling-Enhancing patient outcomes. East Islip, NY, Program Management Services Inc, 1992
18. Owen JC: the pharmacists duty to warn: Lasley v Shrake's country club pharmacy. Arizona Law Review 37:677-700,1995
19. Moloney TW, Rogers DE: Medical technology: A different view of the contenious debate over costs. N Engl J Med 301:1413-1419,1979
20. Manning WG, Newhouse JP, Dan N, et al: Health incurance and the demand for medical care: Evidence from a random experiment. Am Econ Rev 77:251-257,1987
21. Coddington, et al: Financial impact of population growth and aging, in: The Crisis in Health Care. San Francisco, CA, Jossey-Bass, 1991
22. Gonzalez ML, Emmons DW: Socioeconomic characteristics of medical practice. Chicago, IL, American Medical Association, 1989
23. Levit KR: National health care spending 1989. Health Aff 10:119-130,1991